{
  "id": 1001613,
  "title": "Knight-Swift CEO Reid Dove sells $12.3m in company stock",
  "url": "https://urgent.news/2026/08/15/knight-swift-ceo-reid-dove-sells-12-3m-in-company-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-15T08:46:34.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/knightswift-ceo-reid-dove-sells-123m-in-company-stock-93CH-4861757"
  },
  "original_language": "en",
  "account": "Knight-Swift Transportation Holdings CEO Reid Dove sold $12.3 million worth of company stock in two transactions during mid-August. The shares were sold at prices ranging from $71.49 to $73.13 per share. As of August 2026, KNX shares had increased by approximately 73%, currently trading at $72.42 with a market capitalization of $11.93 billion. Dove indirectly sold 42,290 shares on August 12th at an average price of $71.49 per share, leaving 126,864 shares with a foundation. The next day, Dove sold another 126,864 shares at a weighted average price of $73.13 per share, reducing the foundation's ownership to zero.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Edgewise Therapeutics CEO Kevin Koch sells $785,042 in stock",
        "url": "https://urgent.news/2026/08/15/edgewise-therapeutics-ceo-kevin-koch-sells-785-042-in-stock",
        "published": "2026-08-15T04:01:04.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}